Back Pain: Although rare, back pain has been reported
As much of the MRS evidence in schizophrenia relates to the ACC, this was our primary region of interest
Highlights: GLP-1 receptor drugs cause meaningful and sustained weight loss compared to placebo Industry funding raises concerns over potential bias and long-term safety gaps Independent and equitable access to these medications remains a global priority questions persist about potential biases and long-term impacts
The quality of life was assessed using the EuroQol 5-Dimension 5-Level Questionnaire (EQ-5D-5L)
Restarting at your previous dose after such a break could lead to severe gastrointestinal issues
frankly, they should just never be used, Adarsh Vijay Mudgil, MD, board-certified dermatologist and founder of New York City's Mudgil Dermatology, tells Glamour, and Dr